AMGEN INC (NASDAQ: AMGN)





$57.22 -0.24 (-0.42%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
64.76
52-Week Low Price
44.96
Avg Volume (3 Mo.)
7.00 M
Market Cap
58.38 B
P/E Ratio (TTM)
12.8
Diluted EPS (TTM)
5.04
Shares
1012.14 M
Dividend Rate ($) / (%)
0.00/0.00
89%
11%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 0% - AMGN has underperformed the S&P 500 by 26%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
MERCK & COMPANY; INC. (MRK) $36.38 -  $0.22(0.59%)113.83 B
GLAXOSMITHKLINE PLC (GSK) $38.51 -  $0.39(1.02%)107.74 B
SANOFI-AVENTIS ADS (SNY) $36.38 -  $0.47(1.31%)93.43 B
ABBOTT LABORATORIES (ABT) $53.49 -  $0.14(0.26%)83.48 B
ASTRAZENECA PLC (AZN) $44.19 -  $1.06(2.46%)62.34 B
TEVA PHARMACEUTICAL LTD (TEVA) $57.22 -  $0.30(0.53%)51.77 B
BRISTOL-MYERS SQUIBB CO (BMY) $24.26 -  $0.30(1.25%)47.48 B
GILEAD SCIENCES INC (GILD) $46.39 -  $0.30(0.65%)41.74 B
ELI LILLY & CO (LLY) $35.22 -  $0.44(1.27%)39.66 B
NOVO NORDISK A/S (NVO) $69.47 -  $0.33(0.48%)36.54 B
STOCK ANALYSIS
Stock Analysis
Forest Labs' Oh-So-Healthy Balance Sheet (FRX, PFE, BIIB, AMGN, GENZ)
This company has a pristine capital structure and a stockpile of cash, but the best part is that its stock is cheap.
Stock Analysis
Great Expectations For Apple (AAPL, TXN, AMGN, SLG)
Apple will be the most closely watched company to report quarterly earnings January 25, but several other big names...
Stock Analysis
Large Cap Biotech Earnings Preview (BIIB, ACOR, FACT, GILD, AMGN, NVS)
Biotech stocks traditionally fare well through recessions. We'll see if that holds true.
Stock Analysis
The 5 Most Important Drugs In America (PFE, BMY, AZN, AMGN, WYE)
A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than o...
Stock Analysis
Stock Buybacks Fall Off A Cliff (XOM, IBM, AMGN, ORCL, PM)
We take a look at the stock repurchase report from S&P, to see what is signals for the economy.
AMGN RELATED HEADLINES
arrow
Amgen (AMGN) Appears On Investors Observer Analysts Favorites List
Amgen (NASDAQ: AMGN) closed yesterday at $57.46. So far the stock has hit a 52-week low of $44.96 and 52-week high of $64.76. Amgen stock has been showing support around 56.14 and resistance in the 58.58 range. Technical indicators for the stock are Bullish and S&P gives AMGN a positive 4 STAR (out of 5) buy rating. AMGN appears on the Investors Observer Analysts Favorites list. For a hedged play on this stock, look at an Apr '10 60 covered call for a net debit in the $55.96 area. That is also the break even stock price for this trade. This covered call has a 67 day duration, provides 2.61% do...

At Market Intelligence Center 2/9/2010
arrow
Liberty Analytics Co. Initiates Independent Research Coverage on Amgen
Liberty Analytics Co. Initiates Independent Research Coverage on Amgen

by GlobeNewswire 1/29/2010
arrow
Forest Labs' Oh-So-Healthy Balance Sheet (FRX, PFE, BIIB, AMGN, GENZ)
This company has a pristine capital structure and a stockpile of cash, but the best part is that its stock is cheap.

at Investopedia Advisor 1/26/2010
arrow
Doubts Build On Glaxo's Antiaging Drugs
The drugmaker bet $720 million on drugs based on the wine-ingredient resveratrol. New studies suggest that the drugs won't work.

Forbes.com 1/26/2010
arrow
Put Volume Spikes on Amgen, Inc. Ahead of Earnings
Amgen, Inc. (AMGN) is scheduled to release its fourth-quarter results after the closing bell today, and option players are loading up on puts ahead of the event...(Read More)

By SchaeffersResearch 1/25/2010
arrow
Great Expectations For Apple (AAPL, TXN, AMGN, SLG)
Apple will be the most closely watched company to report quarterly earnings January 25, but several other big names are also set to announce their earnings.

at Investopedia Advisor 1/25/2010
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1